Media coverage
2
Media coverage
Title -Horizon Therapeutics plc - Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjogren's syndrome Media name/outlet M2 PressWIRE Country/Territory United States Date 1/06/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68C6-VH31-JD3Y-Y285-00000-00 Persons Wan Fai Ng Title -Horizon Therapeutics plc - Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjogren's syndrome Media name/outlet ENP Newswire Country/Territory United Kingdom Date 1/06/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68C6-VH31-JD3Y-Y1TS-00000-00 Persons Wan Fai Ng